Non-Hodgkin's lymphoma in a patient on treatment with temozolomide

Asia Pac J Clin Oncol. 2012 Dec;8(4):e53-4. doi: 10.1111/j.1743-7563.2011.01500.x. Epub 2012 May 7.

Abstract

A 68-year-old man was diagnosed with glioblastoma multiforme of the right basal ganglia in March 2010. He was treated with radiotherapy and concurrent chemotherapy with daily temozolomide for over 6 weeks. During the maintenance phase of treatment with temozolomide, he developed a swelling in the left cheek; a biopsy of which proved to be non-Hodgkin's lymphoma. The temozolomide was stopped and the lymphoma was successfully treated with chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Cerebellar Neoplasms / drug therapy*
  • Cerebellar Neoplasms / radiotherapy
  • Chemoradiotherapy
  • Dacarbazine / administration & dosage
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives*
  • Glioblastoma / drug therapy*
  • Glioblastoma / radiotherapy
  • Humans
  • Lymphoma, Non-Hodgkin / chemically induced*
  • Male
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide